Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2023

Feb 21, 2023

30893_dirs_2023-02-21_92790082-609f-41ed-84a2-8256b84c76da.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2023-02-16

Reporting Person: Nash Kevin C (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-16 Common Stock A 9874.00 $0.00 Acquired 32471.00 Direct
2023-02-21 Common Stock A 7129.00 $0.00 Acquired 39600.00 Direct
2023-02-21 Common Stock F 3102.00 $28.65 Disposed 36498.00 Direct
2023-02-21 Common Stock F 2414.00 $28.65 Disposed 34084.00 Direct

Footnotes

F1: These shares vest 100% three years from grant award date.

F2: 7,129 shares are performance based shares where the total number of shares granted were based on long term performance incentives.